Developer docs
API playgroundTry for free, no card

Search company profiles

France Biotech

Full company profile

uuid000fh2e

Namestring
France Biotech
Legal namestring
France Biotech
Company typeenum
Private
Founded yearint
1997
Descriptiontext

France Biotech is an independent non-profit association founded in 1997 under French law (loi du 1er juillet 1901), registered as SIREN 417 666 278, and headquartered at PariSanté Campus in Paris's 15th arrondissement. It functions as the recognized representative body for French health innovation entrepreneurs, serving biotechnology, medical device, and digital health/AI companies as well as broader health ecosystem stakeholders including public authorities and healthcare institutions. The association's stated mission is to serve as a one-stop trade and joint-action platform for the industry, addressing fragmentation in the French HealthTech ecosystem through coordinated representation, networking, and expert support.

The association's portfolio comprises service-oriented rather than software products: the annual Panorama France HealthTech report (now in its 23rd edition), the Trophées de la HealthTech awards (5th edition), the Permanences Expertes platform connecting members to approximately 60 specialists across strategic, regulatory, financial, and legal domains, the Expert and Company directories, France Biotech TV (webinar/video library), a job board, and the annual Data Transformeurs conference on AI applied to public health. France Biotech also operates international programs, including French HealthTech delegations to BIO International Convention (San Diego, June 2026) and the Forum France-Chine (Paris and Lyon, July 2026), and maintains an ecosystem of roughly 30 institutional partners spanning Bpifrance, Business France, Euronext, La French Tech, LEEM, MedTech in France, France Deeptech, Resah, regional clusters (Lyonbiopole, Medicen Paris Region, Atlanpole Biotherapies), and others.

The business model is membership-funded: France Biotech is a non-profit association relying on recurring membership dues from HealthTech companies and partners rather than product revenue. Membership pricing is not publicly disclosed. The association serves an ecosystem of approximately 2,700 HealthTech companies employing around 80,000 people, with the broader sector raising €2.3 billion in capital in 2025 (down 9% overall, though venture capital grew 15% to €1.028 billion) and France ranking second in Europe for capital raised and first in Europe for HealthTech transaction count. Governance is led by President Frédéric Girard.

Short descriptiontext

France Biotech is an independent non-profit association founded in 1997 that represents French HealthTech entrepreneurs across biotech, medical devices, and digital health, providing advocacy, expert advisory, annual benchmarking reports, awards, and international delegations funded by membership dues.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
HealthTech industry association, biotech sector advocacy, health innovation networking, industry policy representation, ecosystem expert advisory
Industry2 codes
1Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
CodeBPADANAJPrimaryYes
2Technical Committees, Working Groups & Expert Panels
CodeBPADANABPrimaryNo
Product category
HealthTech Industry Association Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Membership dues
TypeSubscription Recurring
Description

France Biotech operates as a non-profit association funded through membership dues from HealthTech companies and partners. The association does not charge for its public-facing services but relies on member contributions for operational sustainability.

france-biotech.fr
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Panorama France HealthTech
Description

Annual industry report analyzing the French HealthTech ecosystem, now in its 23rd edition as of 2026.

france-biotech.fr
+1 more record
Core offering1 text field

France Biotech is a French non-profit industry association founded in 1997 that federates health innovation entrepreneurs across biotechnology, medical devices, and digital health/AI. It delivers member services including access to a network of approximately 60 experts for strategic, regulatory, financial, and legal guidance, the annual Panorama France HealthTech industry report, the Trophées de la HealthTech awards program, international delegation representation (e.g., BIO International Convention, Forum France-Chine), policy advocacy with public authorities, and facilitation of partnerships with public and private ecosystem stakeholders such as Bpifrance, Business France, Euronext, and regional clusters.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Representing over 2,700 HealthTech companies comprising the French ecosystem
+2 more records
Product overview1 text field

France Biotech is an independent association founded in 1997 that serves as a federation of health innovation entrepreneurs and their expert partners. The organization does not offer a unified software product but rather provides a portfolio of services including the annual Panorama France HealthTech publication (now in its 23rd/24th edition), the Trophées de la HealthTech awards program, an expert advisory platform ('Permanences Expertes') connecting members with approximately 60 specialists, a company directory of HealthTech members, France Biotech TV video content platform featuring webinars and startup profiles, a job board, and international event participation including BIO International Convention and Forum France-Chine. The association also facilitates partnerships with approximately 30 organizations including Bpifrance, Business France, La French Tech, and regional biotech clusters.

Product and service5 records
1Panorama France HealthTech
CategoryIndustry Report / Publication
Description

Annual industry benchmark publication analyzing the French HealthTech ecosystem, covering company statistics, funding data, R&D investments, and sector trends for biotech, medtech, and digital health/AI companies.

2Trophées de la HealthTech
CategoryAwards Program
Description

Annual awards program recognizing excellence and innovation among French HealthTech companies, currently in its 5th edition, available to member companies and the broader ecosystem.

3Permanences Expertes Platform
CategoryExpert Advisory Service
Description

Online advisory platform connecting HealthTech entrepreneurs with approximately 60 expert members who provide guidance on strategic, regulatory, financial, and legal challenges; offered as a member benefit.

4International Events Program (BIO International Convention / Forum France-Chine)
CategoryEvent Series / Delegation Program
Description

Curated international participation and delegation program for French HealthTech companies at major industry conventions to support global visibility and export development.

5Data Transformeurs Conference
CategoryAnnual Conference
Description

Annual conference dedicated to data and artificial intelligence applied to public health, held at Hôtel-Dieu de Paris, gathering 200 selected participants since its creation in 2023.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

Business France is a key partner for international development, organizing events like the Forum France-Chine and providing export support for French HealthTech companies looking to expand abroad.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

La French Tech is a key ecosystem partner supporting French Tech startups and growth companies including HealthTech innovators.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Resah (Réseau des Achats Hospitaliers) is the national purchasing center for hospitals. France Biotech partnered with Resah to help member companies access the public hospital market through webinars and guidance on procurement procedures.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

MedTech in France is the French medtech industry association, working with France Biotech on shared ecosystem development and regulatory harmonization.

5France Deeptech
Strategic tierCoreTypeStrategic or Co-development Partner
Description

France Deeptech supports deep tech startups including HealthTech companies with significant R&D components, aligning with France Biotech's innovation focus.

france-biotech.fr
Strategic tierMajorTypeStrategic or Co-development Partner
Description

LEEM represents pharmaceutical companies in France, working with France Biotech on shared interests between biotech startups and established pharma.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

MabDesign is the industry association for antibodies and biotherapies, supporting innovation in the biopharmaceutical sector.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

FemTech France focuses on women's health innovation, complementing France Biotech's broader HealthTech representation.

Strategic tierMajorTypeGTM or Marketing Partner
Description

French Healthcare Association promotes French health expertise internationally, supporting the global positioning of French HealthTech companies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

France Digitale represents digital tech companies, supporting cross-pollination with digital health innovators in the France Biotech ecosystem.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Lyonbiopole is a competitive cluster for biomedical innovation in the Lyon area, one of several regional clusters partnering with France Biotech.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Medicen Paris Region is a healthcare innovation cluster in the Paris area, supporting HealthTech companies in the Greater Paris region.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Atlanpole Biotherapies is a regional competitiveness cluster supporting biotherapy innovation in the Atlantic region.

Strategic tierMinorTypeGTM or Marketing Partner
Description

CCE provides international trade expertise through its network of Foreign Trade Advisors, supporting HealthTech companies' export strategies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US biotech trade association representing member companies across healthcare, agricultural, and industrial biotechnology. Directly comparable as a national biotech/HealthTech industry voice, but operating at a much larger US scale; runs the BIO International Convention that France Biotech's members attend in delegation.

TypeDirect peer
Description

European Association for Bioindustries representing biotech companies and national biotech associations across the EU. Directly comparable as the umbrella industry voice for European biotech of which France Biotech is effectively a national affiliate, with shared policy advocacy on EU regulation.

TypeDirect peer
Description

UK national biotech trade association representing innovative bioscience and HealthTech member companies. Closely comparable to France Biotech in mandate (national trade body, policy advocacy, member services, events) and similar size/maturity.

TypeDirect peer
Description

German biotechnology industry association representing biotech SMEs in Germany. Same operational model as France Biotech - national, member-funded, focused on biotech and adjacent HealthTech - and a frequent partner at European industry fora.

TypeRegional player
Description

Spanish Bioindustry Association representing biotech companies and stakeholders in Spain. Same operational model and industry focus as France Biotech, but serving the Spanish national ecosystem rather than the French one.

TypeRegional player
Description

National biotech industry association in Switzerland with member services, policy advocacy, and the annual Swiss Biotech Day. Highly comparable structure to France Biotech, focused on a smaller but very R&D-intensive national ecosystem.

TypeBroad incumbent
Description

European trade association for medical technology (diagnostic and medical devices) industries. Directly overlaps with France Biotech's medtech segment but operates at a broader European level across all medtech categories.

TypeDirect peer
Description

French pharmaceutical industry association representing drug companies operating in France. Closely comparable trade-association mission and Paris footprint, but focused on established pharma rather than innovative HealthTech startups.

TypeDirect peer
Description

French medical device industry association representing medtech companies in France. Overlaps directly with one of France Biotech's three core member segments (medical devices); already a partner organization and a competing voice for medical-device representation.

TypeOthers
Description

French organization promoting French health expertise internationally, including HealthTech exporters. Already a partner of France Biotech for international promotion, so a thematic/adjacent peer rather than a substitute.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

France Biotech

HealthTech Industry Association Servicesfrance-biotech.fr

France Biotech is an independent non-profit association founded in 1997 that represents French HealthTech entrepreneurs across biotech, medical devices, and digital health, providing advocacy, expert advisory, annual benchmarking reports, awards, and international delegations funded by membership dues.

What France Biotech does

France Biotech is an independent non-profit association founded in 1997 under French law (loi du 1er juillet 1901), registered as SIREN 417 666 278, and headquartered at PariSanté Campus in Paris's 15th arrondissement. It functions as the recognized representative body for French health innovation entrepreneurs, serving biotechnology, medical device, and digital health/AI companies as well as broader health ecosystem stakeholders including public authorities and healthcare institutions. The association's stated mission is to serve as a one-stop trade and joint-action platform for the industry, addressing fragmentation in the French HealthTech ecosystem through coordinated representation, networking, and expert support.

The association's portfolio comprises service-oriented rather than software products: the annual Panorama France HealthTech report (now in its 23rd edition), the Trophées de la HealthTech awards (5th edition), the Permanences Expertes platform connecting members to approximately 60 specialists across strategic, regulatory, financial, and legal domains, the Expert and Company directories, France Biotech TV (webinar/video library), a job board, and the annual Data Transformeurs conference on AI applied to public health. France Biotech also operates international programs, including French HealthTech delegations to BIO International Convention (San Diego, June 2026) and the Forum France-Chine (Paris and Lyon, July 2026), and maintains an ecosystem of roughly 30 institutional partners spanning Bpifrance, Business France, Euronext, La French Tech, LEEM, MedTech in France, France Deeptech, Resah, regional clusters (Lyonbiopole, Medicen Paris Region, Atlanpole Biotherapies), and others.

The business model is membership-funded: France Biotech is a non-profit association relying on recurring membership dues from HealthTech companies and partners rather than product revenue. Membership pricing is not publicly disclosed. The association serves an ecosystem of approximately 2,700 HealthTech companies employing around 80,000 people, with the broader sector raising €2.3 billion in capital in 2025 (down 9% overall, though venture capital grew 15% to €1.028 billion) and France ranking second in Europe for capital raised and first in Europe for HealthTech transaction count. Governance is led by President Frédéric Girard.

France Biotech firmographics

Firmographics
Name
France Biotech
Legal name
France Biotech
Website
https://france-biotech.fr
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
51–100 employees
Short description
France Biotech is an independent non-profit association founded in 1997 that represents French HealthTech entrepreneurs across biotech, medical devices, and digital health, providing advocacy, expert advisory, annual benchmarking reports, awards, and international delegations funded by membership dues.
Ownership category
akta.pro rank

France Biotech industry classification

Industry
Product category
HealthTech Industry Association Services
akta.pro primary industry
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
akta.pro secondary industry
Technical Committees, Working Groups & Expert Panels (BPADANAB)

Keywords

  • HealthTech industry association
  • Biotech sector advocacy
  • Health innovation networking
  • Industry policy representation
  • Ecosystem expert advisory

Where France Biotech is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

France Biotech business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Membership dues: France Biotech operates as a non-profit association funded through membership dues from HealthTech companies and partners. The association does not charge for its public-facing services but relies on member contributions for operational sustainability.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

France Biotech product offering

Product offering

Core offering

France Biotech is a French non-profit industry association founded in 1997 that federates health innovation entrepreneurs across biotechnology, medical devices, and digital health/AI. It delivers member services including access to a network of approximately 60 experts for strategic, regulatory, financial, and legal guidance, the annual Panorama France HealthTech industry report, the Trophées de la HealthTech awards program, international delegation representation (e.g., BIO International Convention, Forum France-Chine), policy advocacy with public authorities, and facilitation of partnerships with public and private ecosystem stakeholders such as Bpifrance, Business France, Euronext, and regional clusters.

Product overview

France Biotech is an independent association founded in 1997 that serves as a federation of health innovation entrepreneurs and their expert partners. The organization does not offer a unified software product but rather provides a portfolio of services including the annual Panorama France HealthTech publication (now in its 23rd/24th edition), the Trophées de la HealthTech awards program, an expert advisory platform ('Permanences Expertes') connecting members with approximately 60 specialists, a company directory of HealthTech members, France Biotech TV video content platform featuring webinars and startup profiles, a job board, and international event participation including BIO International Convention and Forum France-Chine. The association also facilitates partnerships with approximately 30 organizations including Bpifrance, Business France, La French Tech, and regional biotech clusters.

Differentiator

Problem solved

Functional benefit

Brands

  • Panorama France HealthTech: Annual industry report analyzing the French HealthTech ecosystem, now in its 23rd edition as of 2026.
  • Trophées de la HealthTech

Products and services

  • Panorama France HealthTech Annual industry benchmark publication analyzing the French HealthTech ecosystem, covering company statistics, funding data, R&D investments, and sector trends for biotech, medtech, and digital health/AI companies.
  • Trophées de la HealthTech Annual awards program recognizing excellence and innovation among French HealthTech companies, currently in its 5th edition, available to member companies and the broader ecosystem.
  • Permanences Expertes Platform Online advisory platform connecting HealthTech entrepreneurs with approximately 60 expert members who provide guidance on strategic, regulatory, financial, and legal challenges; offered as a member benefit.
  • International Events Program (BIO International Convention / Forum France-Chine) Curated international participation and delegation program for French HealthTech companies at major industry conventions to support global visibility and export development.
  • Data Transformeurs Conference Annual conference dedicated to data and artificial intelligence applied to public health, held at Hôtel-Dieu de Paris, gathering 200 selected participants since its creation in 2023.

Quantifiable outcome

  • Representing over 2,700 HealthTech companies comprising the French ecosystem
  • +2 more outcomes

Companies that use France Biotech

Customer profile

Segments4 records

Ideal customer profiles2 records

France Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

France Biotech partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core, major and minor.

  • Business FrancecoreGTM or Marketing PartnerBusiness France is a key partner for international development, organizing events like the Forum France-Chine and providing export support for French HealthTech companies looking to expand abroad.
  • La French TechcoreStrategic or Co-development PartnerLa French Tech is a key ecosystem partner supporting French Tech startups and growth companies including HealthTech innovators.
  • ResahmajorStrategic or Co-development PartnerResah (Réseau des Achats Hospitaliers) is the national purchasing center for hospitals. France Biotech partnered with Resah to help member companies access the public hospital market through webinars and guidance on procurement procedures.
  • MedTech in FrancemajorStrategic or Co-development PartnerMedTech in France is the French medtech industry association, working with France Biotech on shared ecosystem development and regulatory harmonization.
  • France DeeptechcoreStrategic or Co-development PartnerFrance Deeptech supports deep tech startups including HealthTech companies with significant R&D components, aligning with France Biotech's innovation focus.
  • LEEM (Les Entreprises du Médicament)majorStrategic or Co-development PartnerLEEM represents pharmaceutical companies in France, working with France Biotech on shared interests between biotech startups and established pharma.
  • MabDesignminorStrategic or Co-development PartnerMabDesign is the industry association for antibodies and biotherapies, supporting innovation in the biopharmaceutical sector.
  • FemTech FranceminorStrategic or Co-development PartnerFemTech France focuses on women's health innovation, complementing France Biotech's broader HealthTech representation.
  • French HealthcaremajorGTM or Marketing PartnerFrench Healthcare Association promotes French health expertise internationally, supporting the global positioning of French HealthTech companies.
  • France DigitaleminorStrategic or Co-development PartnerFrance Digitale represents digital tech companies, supporting cross-pollination with digital health innovators in the France Biotech ecosystem.
  • LyonbiopolemajorStrategic or Co-development PartnerLyonbiopole is a competitive cluster for biomedical innovation in the Lyon area, one of several regional clusters partnering with France Biotech.
  • Medicen Paris RegionmajorStrategic or Co-development PartnerMedicen Paris Region is a healthcare innovation cluster in the Paris area, supporting HealthTech companies in the Greater Paris region.
  • Atlanpole BiotherapiesminorStrategic or Co-development PartnerAtlanpole Biotherapies is a regional competitiveness cluster supporting biotherapy innovation in the Atlantic region.
  • CCI France (Conseillers du Commerce Extérieur)minorGTM or Marketing PartnerCCE provides international trade expertise through its network of Foreign Trade Advisors, supporting HealthTech companies' export strategies.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

France Biotech competitors and assessment

Company assessment

Direct peers

  • Biotechnology Innovation Organization (BIO): US biotech trade association representing member companies across healthcare, agricultural, and industrial biotechnology. Directly comparable as a national biotech/HealthTech industry voice, but operating at a much larger US scale; runs the BIO International Convention that France Biotech's members attend in delegation.
  • EuropaBio: European Association for Bioindustries representing biotech companies and national biotech associations across the EU. Directly comparable as the umbrella industry voice for European biotech of which France Biotech is effectively a national affiliate, with shared policy advocacy on EU regulation.
  • BioIndustry Association (BIA): UK national biotech trade association representing innovative bioscience and HealthTech member companies. Closely comparable to France Biotech in mandate (national trade body, policy advocacy, member services, events) and similar size/maturity.
  • BIO Deutschland: German biotechnology industry association representing biotech SMEs in Germany. Same operational model as France Biotech - national, member-funded, focused on biotech and adjacent HealthTech - and a frequent partner at European industry fora.
  • LEEM (Les Entreprises du Médicament): French pharmaceutical industry association representing drug companies operating in France. Closely comparable trade-association mission and Paris footprint, but focused on established pharma rather than innovative HealthTech startups.
  • Snitem (MedTech in France): French medical device industry association representing medtech companies in France. Overlaps directly with one of France Biotech's three core member segments (medical devices); already a partner organization and a competing voice for medical-device representation.

Regional players

  • AseBio: Spanish Bioindustry Association representing biotech companies and stakeholders in Spain. Same operational model and industry focus as France Biotech, but serving the Spanish national ecosystem rather than the French one.
  • Swiss Biotech Association: National biotech industry association in Switzerland with member services, policy advocacy, and the annual Swiss Biotech Day. Highly comparable structure to France Biotech, focused on a smaller but very R&D-intensive national ecosystem.

Broad incumbents

  • MedTech Europe: European trade association for medical technology (diagnostic and medical devices) industries. Directly overlaps with France Biotech's medtech segment but operates at a broader European level across all medtech categories.

Others

  • French Healthcare Association: French organization promoting French health expertise internationally, including HealthTech exporters. Already a partner of France Biotech for international promotion, so a thematic/adjacent peer rather than a substitute.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

France Biotech social profiles

Digital presence

France Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

France Biotech leadership team

Management profile

Number of profiles

Profiles4 records

France Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

France Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about France Biotech

What does France Biotech do?

France Biotech is a French non-profit industry association founded in 1997 that federates health innovation entrepreneurs across biotechnology, medical devices, and digital health/AI. It delivers member services including access to a network of approximately 60 experts for strategic, regulatory, financial, and legal guidance, the annual Panorama France HealthTech industry report, the Trophées de la HealthTech awards program, international delegation representation (e.g., BIO International Convention, Forum France-Chine), policy advocacy with public authorities, and facilitation of partnerships with public and private ecosystem stakeholders such as Bpifrance, Business France, Euronext, and regional clusters.

Is France Biotech a public or private company?

France Biotech is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was France Biotech founded?

France Biotech was founded in 1997. It employs 51 to 100 people.

Where is France Biotech based?

France Biotech is headquartered in Paris, France, in the Europe region.

How does France Biotech make money?

One revenue line is on record: membership dues.

Who are France Biotech's main competitors?

Direct peers on record are Biotechnology Innovation Organization (BIO), EuropaBio, BioIndustry Association (BIA), BIO Deutschland, LEEM (Les Entreprises du Médicament) and Snitem (MedTech in France). Regional players are AseBio and Swiss Biotech Association. MedTech Europe is listed as a broad incumbent. French Healthcare Association is listed as an others.

Does France Biotech have an API?

No public API is recorded for France Biotech.

What industry is France Biotech in?

France Biotech's product category is HealthTech Industry Association Services. Its primary akta.pro industry code is BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation, with a secondary code of BPADANAB, Technical Committees, Working Groups & Expert Panels.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MaddynessFrance Biotech veut flécher l'épargne des particuliers vers les startups de la santéFrance Biotech is urging private savings to fund health startups, citing that 60% of French health companies have six months or less of cash. The association proposes dedicated investment products and a label for innovative health funds. Fundraising rose 70% in the first half of the year, but only five companies captured nearly half of the funds.YahooFrance Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International Convention 2026 in San DiegoFrance Biotech, the French association representing health innovation entrepreneurs, will participate in the BIO International Convention 2026 in San Diego from June 22-25, showcasing French HealthTech strength through dedicated sessions and a French Pavilion booth. According to the Panorama France HealthTech 2026 report, the French HealthTech ecosystem comprises over 2,700 companies, ranks second in Europe for capital raised in 2025, and employs around 80,000 people, with 74% of companies targeting international markets from early development stages.FinancialContent Business PageFrance Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International Convention 2026 in San DiegoFrance Biotech, the French association representing health innovation entrepreneurs, will attend the BIO International Convention 2026 in San Diego from June 22-25 alongside a delegation of French HealthTech companies, hosting two sessions on the international development of the French biotech ecosystem. The French HealthTech sector has grown to include over 2,700 companies, raised €2.3 billion in 2025 including €1 billion in venture capital (up 15% year-on-year), and ranks second in Europe for capital raised. The event will feature panel discussions with speakers from companies including Cilcare, Biomunex Pharmaceuticals, and AQEMIA, with 74% of French HealthTech companies targeting international markets from early development stages.GlobeNewswireFrance Biotech to Showcase the Strength and GlobalFrance Biotech, the French health innovation association representing over 2,700 HealthTech companies, will lead a delegation of French biotech firms at the BIO International Convention 2026 in San Diego from June 22-25, participating in sessions on the French ecosystem and international expansion strategies. The French HealthTech sector raised €2.3 billion in 2025, ranking second in Europe for capital raised and first in number of transactions, with nearly 40% of its workforce dedicated to R&D. The event aims to strengthen international collaborations and showcase France's scientific excellence to global investors and pharmaceutical companies.GlobeNewswireFocus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environmentFrance Biotech released the 23rd Panorama France HealthTech 2026 study, covering nearly 2,800 companies. The sector shows resilience with stable creation and insolvency levels, but faces a global financing slowdown, with venture capital up 15% to €1.028 billion in 2025. AI adoption is widespread, and companies are increasingly targeting international markets.GlobeNewswireFocus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environmentFrance Biotech released the 23rd edition of its annual Panorama France HealthTech 2026 report, analyzing a maturing ecosystem of nearly 2,800 innovative companies in biotechnology, medical devices and digital health/AI. French HealthTech companies raised €2.3 billion in 2025, down 9% overall, though venture capital showed resilience with 15% growth to €1.028 billion, driven by three major funding rounds exceeding €60 million each. The sector faces increasing pressures with only 20% of companies successfully raising funds, 41% reporting cash-flow difficulties, and 75% impacted by the challenging financing environment, while generative AI adoption reaches 65% across the ecosystem.The French Tech JournalMapping French TechBio: 40 Companies Mixing Biology, Data, and AIA report by France Biotech and France Deeptech highlights the emergence of 40 TechBio companies in France, nearly doubling in number within a year, as part of a growing ecosystem aimed at becoming a global leader in this field. The report emphasizes that these companies leverage advanced technology as their main value driver, with significant investments continuing to flow into the sector despite challenging funding conditions. The French TechBio landscape is bolstered by government recognition and a strong academic foundation, although competition from international players remains a concern.The French Tech JournalSkeepers: Building a European SaaS Powerhouse with American CapitalFrance Biotech and France Deeptech have identified 40 companies at the intersection of biology and technology, suggesting France's potential to become a global leader in this sector. Concurrently, Brevo achieved a €1bn valuation through a PE-led growth buyout involving General Atlantic and Oakley, which facilitates its U.S. expansion and AI-driven growth.GlobeNewswireERYTECH to Participate in the HealthTech Innovation Days (HTID) by France BiotechERYTECH Pharma will participate in HealthTech Innovation Days investor meetings on October 4-5, 2021, with CEO Gil Beyen and CFO Eric Soyer. The company's lead product eryaspase is in Phase 3 for pancreatic cancer, with top-line results expected in Q4 2021, and has received FDA Fast Track and orphan drug designations.TechCrunchFrance gives startups tax breaks. And now plans to take them back.The French government is planning to reform the Jeune Entreprise Innovante (JEI) tax scheme starting in 2011, introducing a €103,000 cap on tax breaks per company and limiting exemptions to social security contributions for salaries less than 4 times the minimum wage, in an effort to save approximately 57 million euros annually. French startup entrepreneurs and associations like France Biotech are strongly opposing the reform, arguing it will discourage innovation and push companies to offshore operations, with over 600 entrepreneurs joining a Facebook group to save the JEI. The reform would also introduce progressive reduction of tax exemptions starting from the fourth year of a startup's life.